InSilicoTrials is an emerging startup founded in 2018 by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize Healthcare through an innovative digital simulation platform. We have developed a cloud-based platform that provides a user-friendly computational modeling and simulation environment where many integrated, easy-to-use in silico tools are readily available. Our mission is “Hyper-accelerate drug and medical device development through in silico trials”, while our vision: is “Boost the world’s transition to accessible therapies”. We provide novel AI tools, Modeling and Simulation (M&S) and computational models to: 1) improve safety of drugs and medical devices, 2) significantly cut R&D costs and time, 3) reduce, refine and replace tests on animals and clinical trials. The platform primarily targets users from the medical devices and pharmaceutical sectors. The in silico tools available for medical devices enable computational testing in different biomedical areas like radiology, orthopedics, and cardiovascular during product design, development and validation processes. For the pharmaceutical sector, the platform provides access to in silico tools developed at all stages of the drug discovery and development processes and for many different therapeutic areas.